415 related articles for article (PubMed ID: 28642119)
1. Targeting inflammation for the treatment of alcoholic liver disease.
Xu MJ; Zhou Z; Parker R; Gao B
Pharmacol Ther; 2017 Dec; 180():77-89. PubMed ID: 28642119
[TBL] [Abstract][Full Text] [Related]
2. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
Kawaratani H; Moriya K; Namisaki T; Uejima M; Kitade M; Takeda K; Okura Y; Kaji K; Takaya H; Nishimura N; Sato S; Sawada Y; Seki K; Kubo T; Mitoro A; Yamao J; Yoshiji H
Int J Mol Med; 2017 Aug; 40(2):263-270. PubMed ID: 28627645
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and Management of Alcoholic Liver Disease.
Farooq MO; Bataller R
Dig Dis; 2016; 34(4):347-55. PubMed ID: 27170388
[TBL] [Abstract][Full Text] [Related]
5. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
Seo W; Jeong WI
World J Gastroenterol; 2016 Jan; 22(4):1348-56. PubMed ID: 26819504
[TBL] [Abstract][Full Text] [Related]
6. Alcohol-associated liver disease.
Mackowiak B; Fu Y; Maccioni L; Gao B
J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38299591
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease.
Boccuto L; Abenavoli L
Ann Hepatol; 2017; 16(4):490-500. PubMed ID: 28612750
[TBL] [Abstract][Full Text] [Related]
8. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
[TBL] [Abstract][Full Text] [Related]
9. Salvianic acid A alleviates chronic alcoholic liver disease by inhibiting HMGB1 translocation via down-regulating BRD4.
Lan Y; Yan R; Shan W; Chu J; Sun R; Wang R; Zhao Y; Wang Z; Zhang N; Yao J
J Cell Mol Med; 2020 Aug; 24(15):8518-8531. PubMed ID: 32596881
[TBL] [Abstract][Full Text] [Related]
10. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 in alcoholic liver disease.
Sun J; Fu J; Li L; Chen C; Wang H; Hou Y; Xu Y; Pi J
Toxicol Appl Pharmacol; 2018 Oct; 357():62-69. PubMed ID: 30165058
[TBL] [Abstract][Full Text] [Related]
12. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
[TBL] [Abstract][Full Text] [Related]
13. Natural compounds in the chemoprevention of alcoholic liver disease.
Tu Y; Zhu S; Wang J; Burstein E; Jia D
Phytother Res; 2019 Sep; 33(9):2192-2212. PubMed ID: 31264302
[TBL] [Abstract][Full Text] [Related]
14. Alcoholic liver disease: Utility of animal models.
Lamas-Paz A; Hao F; Nelson LJ; Vázquez MT; Canals S; Gómez Del Moral M; Martínez-Naves E; Nevzorova YA; Cubero FJ
World J Gastroenterol; 2018 Dec; 24(45):5063-5075. PubMed ID: 30568384
[TBL] [Abstract][Full Text] [Related]
15. Wogonin attenuates inflammation by activating PPAR-γ in alcoholic liver disease.
Li HD; Chen X; Yang Y; Huang HM; Zhang L; Zhang X; Zhang L; Huang C; Meng XM; Li J
Int Immunopharmacol; 2017 Sep; 50():95-106. PubMed ID: 28646664
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
Kong LZ; Chandimali N; Han YH; Lee DH; Kim JS; Kim SU; Kim TD; Jeong DK; Sun HN; Lee DS; Kwon T
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159489
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model.
Kawaratani H; Tsujimoto T; Kitazawa T; Yoshiji H; Uemura M; Fukui H
J Gastroenterol Hepatol; 2011 Apr; 26(4):775-83. PubMed ID: 21251062
[TBL] [Abstract][Full Text] [Related]
18. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Epigenetic Modifiers of Alcoholic Liver Disease.
Meroni M; Longo M; Rametta R; Dongiovanni P
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513996
[TBL] [Abstract][Full Text] [Related]
20. The effect of inflammatory cytokines in alcoholic liver disease.
Kawaratani H; Tsujimoto T; Douhara A; Takaya H; Moriya K; Namisaki T; Noguchi R; Yoshiji H; Fujimoto M; Fukui H
Mediators Inflamm; 2013; 2013():495156. PubMed ID: 24385684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
